Skip to main content
Novemeber 2023 Research Awards

November 2023 Research Awards

Investigator Sponsor Type Project Title Begin Date End Date Awarded Dollars
Kamal Abulebda Yale University New Yale-Toyota Collaboration 2/24/2023 2/23/2024 $119,181.00
Jason William Allen Emory University New A novel framework for quantifying metabolic brain health 10/1/2023 8/31/2024 $19,364.00
Jason William Allen Emory University New Cerebral hemodynamic impairment in symptomatic and asymptomatic Alzheimer's Disease 10/1/2023 1/31/2024 $7,041.00
Jason William Allen Emory University New Improved non-invasive MR brain thermometry for therapeutic hypothermia 10/1/2023 12/31/2023 $2,113.00
Tarek Maurice Ashkar University Of Florida Renewal (not prev committed) A Computational Image Analysis Platform (CIMAP) for HuBMAP (Mapping OMICS to Brightfield Histology) 8/1/2023 6/30/2024 $86,188.00
Sandeep Batra Public Health Institute New AOST2032: A Feasibility and Randomized Phase 2/3 Study of the VEFGR2/MET Inhibitor Cabozantinib in Combination with Cytotoxic Chemotherapy for Newly Diagnosed Osteosarcoma 8/31/2022 8/30/2024 $5,784.00
Adnan Tariq Bhutta University Of Maryland New A Pharmacokinetic Study to Evaluate the Use of a Clinical Decision Support Tool in Achieving AUC24/MIC > 400 in Pediatric Patients on Vancomycin (Vanc-Lyv) 10/1/2023 10/31/2024 $18,000.00
Alan Breier Eskenazi Health Renewal (not prev committed) The Prevention and Recovery Center (PARC) for Early Psychosis Coordinated Specialty Care 7/1/2023 6/30/2024 $86,620.00
Bobbi J Byrne American Academy Of Pediatrics New A Picture is Worth a Thousand Lives 1/1/2024 12/31/2024 $14,350.00
Joan M Cook-Mills National Institute Allergy & Infectious Diseases New Development of allergy in offspring is enhanced by maternal eicosanoids and lung microbiota composition dysbiosis. 11/8/2023 10/31/2024 $725,816.00
Jessica L. Davis Nationwide Children's Hospital New Pathology Quality Control Digital Slide Reviews 4/1/2023 3/31/2024 $6,000.00
Michael Denning Davis National Heart, Lung And Blood Institute New Obesity and Childhood Asthma: The Role of Adipose Tissue 11/22/2023 2/29/2024 $490,869.00
Molly Duman Scheel National Institute Allergy & Infectious Diseases New Silencing Anopheles stephensi 11/16/2023 10/31/2024 $213,975.00
Greg Durm Johns Hopkins University New Phase 2 Trial of Neoadjuvant KRAS G12C directed therapy with Adagrasib (MRTX849) with or without Nivolumab in Resectable Non-Small Cell Lung Cancer (Neo-KAN) 8/1/2023 8/1/2026 $101,822.00
Michael T Eadon University Of Florida Renewal (not prev committed) A Computational Image Analysis Platform (CIMAP) for HuBMAP (Mapping OMICS to Brightfield Histology) 8/1/2023 6/30/2024 $86,188.00
Asmaa Elkenawi National Cancer Institute New Targeting tumor cell macrophage lipid interactions to overcome resistance to androgen receptor targeted therapy 9/14/2023 8/31/2025 $423,130.00
Sherif S Farag U.s. Food And Drug Administration New Phase I/II trial of sitagliptin, bortezomib and post-transplant cyclophosphamide for GvHD prophylaxis; IND 158327 (09/03/2021) 9/15/2023 5/31/2024 $648,608.00
Martin Rhys Farlow University Of Southern California Renewal (not prev committed) Alzheimer's Clinical Trials Consortium (ACTC) 9/15/2023 8/31/2024 $409,967.00
Erick Forno National Heart, Lung And Blood Institute New Obesity and Childhood Asthma: The Role of Adipose Tissue 11/22/2023 2/29/2024 $490,869.00
Tatiana M Foroud University Of California, San Diego Renewal (not prev committed) A Seamless Phase 2A-B Randomized Double Blind Placebo Controlled Trial to Evaluate the Efficacy and Safety of PQ912 (varoglutamstat) in Patients with Early Alzheimer's Disease 7/1/2023 6/30/2024 $251,423.34
Tatiana M Foroud Foundation For Peripheral Neuropathy Renewal (not prev committed) Peripheral Neuropathy Research Registry 1/1/2023 12/31/2023 $79,532.00
Nicole R Fowler Dartmouth College New Causes and Consequences of Healthcare Inequity in Alzheimer's Disease and Related Dementias (Core A) 8/15/2023 7/31/2024 $37,354.00
Nicole R Fowler Dartmouth College New Causes and Consequences of Healthcare Inequity in Alzheimer's Disease and Related Dementias (Project 1) 8/15/2023 7/31/2024 $18,678.00
Nicole R Fowler Dartmouth College New Causes and Consequences of Healthcare Inequity in Alzheimer's Disease and Related Dementias (Core B) 8/15/2023 7/31/2024 $11,206.00
Nicole R Fowler Dartmouth College New Causes and Consequences of Healthcare Inequity in Alzheimer's Disease and Related Dementias (Project 3) 8/15/2023 7/31/2024 $18,678.00
Clair A. Francomano Ehlers-danlos Society New Phenotypic relationship between Dercum disease and hypermobile Ehlers-Danlos syndrome 7/1/2023 9/1/2024 $5,000.00
Randall W Grout Vanderbilt University Medical Center New Catalyzing and Harmonizing Operational Innovation for Recruitment (CHOIR) 7/14/2023 4/30/2024 $31,031.00
Stacey L Halum Dysphonia International New Stopping Spasmodic Dysphonia at its Source: A Phase 2 Randomized Controlled Trial of Deep Brain Stimulation for Adductor and Abductor SD 11/15/2023 11/14/2024 $24,000.00
Leng Han National Human Genome Research Institute New MolQTL: A comprehensive resource for molecular quantitative trait loci in human cancer. 6/1/2023 3/31/2024 $396,250.00
Devon J Hensel University Of Minnesota New Training Healthcare Professionals to Address Reproductive Health for People with Disabilities in Tanzania 7/5/2023 6/30/2024 $11,122.00
Onyedika Ilonze Purdue University New Leg heat therapy to improve functional performance in Heart Failure with Preserved Ejection Fraction (HFpEF): a pilot study 7/1/2023 6/30/2024 $77,864.00
Mark H Kaplan Dr. Ralph And Marian Falk Medical Research Trust New Inhibitors Targeting Peanut-Specific Allergic Reactions 11/30/2023 11/29/2026 $999,959.00
Benjamin John Landis National Heart, Lung And Blood Institute New Novel molecular and cardiac imaging paradigms for precision medicine in aortopathy 12/1/2023 11/30/2024 $583,322.00
Lisa Landrum Gog Foundation New A Phase 2/3 Study of Navtemadlin as Maintenance Therapy in Subjects with TP53WT Advanced or Recurrent Endometrial Cancer Who Responded to Chemotherapy 10/31/2023 10/30/2028 $783,796.00
Roxanna Lefort University Hospitals (cleveland) New Pediatric Disaster Medicine Curriculum 9/1/2023 8/31/2024 $60,000.00
Patrick J. Loehrer National Cancer Institute Renewal (not prev committed) IPA Service Agreement for Patrick J. Loehrer, Sr. with the National Cancer Institute 8/1/2023 7/31/2024 $114,526.00
Troy A Markel National Heart, Lung And Blood Institute New Obesity and Childhood Asthma: The Role of Adipose Tissue 11/22/2023 2/29/2024 $490,869.00
Jason Meyer University Of Kentucky Research Foundation New Functions of Chromatin Remodeler Chd7 in Retinal Cell Development 10/1/2023 7/31/2024 $144,065.00
Jason Meyer National Institute On Aging New Targeting P2RX7 Signaling as a Biomarker for ADRD 9/20/2023 5/31/2024 $222,816.00
Anirban Kumar Mitra U.s. Army Medical Research Acquisition Activity New Regulation of Ovarian Cancer Stem Cell Niche by Cancer-Associated Fibroblasts 6/15/2023 6/14/2027 $951,000.00
Brittany Dawn Needham Brain & Behavior Research Foundation New Quantifying an anxiogenic bacterial metabolite in patients with anxiety disorders 1/15/2024 1/14/2026 $70,000.00
Rita R Patel Dysphonia International New Stopping Spasmodic Dysphonia at its Source: A Phase 2 Randomized Controlled Trial of Deep Brain Stimulation for Adductor and Abductor SD 11/15/2023 11/14/2024 $24,000.00
Emanuele Pelosi Yale University New The Genetics and penetrance of the Mullerian Anomalies: Addressing the Challenges of the bench to bedside gap. 8/29/2023 8/28/2025 $114,240.00
Don B Sanders Seattle Children's Research Institute New Standardizing Treatments for Pulmonary Exacerbations: A platform for evaluating treatment decisions to improve outcomes (STOP360) 9/1/2023 12/31/2027 $82,398.00
Andrew J Saykin University Of Wisconsin New Alzheimer's Disease Neuroimaging Initiative (ADNI4) 8/1/2023 7/31/2024 $45,678.00
Michael Lawrence Schulte National Institute On Aging New Targeting P2RX7 Signaling as a Biomarker for ADRD 9/20/2023 5/31/2024 $222,816.00
Emily K Sims University Of Minnesota Renewal (not prev committed) Hybrid Closed Loop Therapy for Beta Cell Preservation in New Onset Type 1 Diabetes (CLVer): Extension Study (CLVerEX) 4/1/2023 3/31/2024 $27,019.00
Michelle Casey Starr National Heart, Lung And Blood Institute New Improving the prediction of bronchopulmonary dysplasia by identifying kidney-based risk factors 12/1/2023 11/30/2024 $181,976.00
Stacey Elaine Tarvin University Of British Columbia New Chronic childhood vasculitis: Characterizing the individual rare diseases to improve patient outcomes (Pediatric Vasculitis Initiative or PedVas Registry) 4/1/2022 3/31/2025 $27,600.00
Stacey Elaine Tarvin Children's Hospital Of Philadelphia Renewal (not prev committed) Immunological, serologic, and imaging biomarker predictors of flare in pediatric spondyloarthritis 9/1/2023 2/29/2024 $6,187.00
Paul R Territo National Institute On Aging New Targeting P2RX7 Signaling as a Biomarker for ADRD 9/20/2023 5/31/2024 $222,816.00
Brownsyne Tucker Edmonds Cleveland Clinic New Engaging Patients in Prenatal Genetic Testing Decisions as a Pathway to Improve Obstetric Outcomes 7/1/2023 2/29/2024 $12,732.00
Kathleen T Unroe University Of Michigan New The Impact of Alzheimer's Disease and Related Dementias on Nursing Home Care and Quality for Persons with Serious Mental Illness 9/30/2023 8/31/2024 $39,939.00
Donna M Wilcock University Of Kentucky Research Foundation New The University of Kentucky MarkVCID Biomarker Validation Cohort: Development of a Toolbox to Advance VCID Interventional Studies 9/1/2023 8/31/2024 $47,254.00
Donna M Wilcock Columbia University New Cerebrovascular contributions to Alzheimer's disease in adults with Down Syndrome 9/1/2023 8/31/2024 $115,626.00
Donna M Wilcock National Institute Neurological Disorders & Stroke New Establishing the role of MMP9 in amyloid-immunotherapy-induced ARIA 11/15/2023 8/31/2025 $1,388,218.00
Amy C Wilson Children's Hospital Of Philadelphia Renewal (not prev committed) Chronic Kidney Disease on Children (CKiD) Study 9/15/2023 7/31/2024 $22,794.00
James Benjamin Wood Arkansas Children's Hospital Res Inst New Short Course Versus Standard Course Antifungal Therapy for Uncomplicated Candidemia in Children and Adolescents: A Multi-Center Randomized Controlled Trial 7/11/2023 7/31/2029 $90,850.00
Amol P. Yadav Indiana Department Of Health New A high-density spinal cord dorsal column stimulation-based sensory neuroprosthetic 7/1/2023 6/30/2025 $160,000.00
Anthony D Yang Northwestern University New Illinois Cancer Collaborative Guideline-Based Molecular Profiling Quality Initiative 3/20/2023 3/19/2024 $7,974.00
S. Elizabeth Zauber Parkinson's Disease Foundation New Parkinson's Center of Excellence 12/1/2023 11/30/2024 $60,000.00
Default Author Avatar IUSM Logo
Author

IU School of Medicine

With more than 60 academic departments and specialty divisions across nine campuses and strong clinical partnerships with Indiana’s most advanced hospitals and physician networks, Indiana University School of Medicine is continuously advancing its mission to prepare healers and transform health in Indiana and throughout the world.

The views expressed in this content represent the perspective and opinions of the author and may or may not represent the position of Indiana University School of Medicine.